Get the tools used by (smart)2 investors.

Predicted Market Cap / Fwd FFO (FY+2) for Cumberland Pharmaceuticals Inc

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

CPIX: Cumberland Pharmaceuticals Inc

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, ...

- USD
Price
USD
Fair Value
Upside
- - -
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Cumberland Pharmaceuticals Inc's Predicted Market Cap / Fwd FFO (FY+2):

CPIXHLTH.USANIPSUPNDRRXZVRACOLL0.0x

Performance Summary
  • Cumberland Pharmaceuticals's predicted market cap / fwd ffo (fy+2) is 0.0x

How does Cumberland's Predicted Market Cap / Fwd FFO (FY+2) benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Cumberland Pharmaceuticals Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Metric Usage: Predicted Market Cap / Fwd FFO (FY+2)

Hide this widget
prediction_market_to_ffo_fwd2
Slug
number
Datatype
text
Format
current
Default Period
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Predicted Market Cap / Fwd FFO (FY+2) in the predictions category include:

  • Predicted EV Growth Exit Rate (FY+5) - Our estimate of the fair value EV Growth Exit Rate (FY+5) for a company.
  • Fair Value Confidence - The percentage increase (if positive) or decrease (if negative) that our models estimate over the current stock price. Fair value serves as a tool for investors and analysts to evaluate whether an asset is overvalued or undervalued in relation to its intrinsic worth.
  • DCF Fair Value Upside - Our estimate of fair value upside for a company using various discounted cash flow analysis methods.
  • DDM Fair Value Upside - Our estimate of fair value upside for a company using various dividend discount models.
View Full List

Search for metric or datapoint

Predicted Market Cap / Fwd FFO (FY+2)

Our estimate of the fair value Market Cap / Fwd FFO (FY+2) for a REIT.

Definition of Predicted Market Cap / Fwd FFO (FY+2)

Hide this widget
Our estimate of the fair value Market Cap / Fwd FFO (FY+2) for a REIT.

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
0.0x0.3x0.5x0.8x1.0x01,0002,000

The chart above depicts the distribution of predicted market cap / fwd ffo (fy+2) for companies operating in the Healthcare sector in the Developed economic region. Over 2,470 companies were considered in this analysis, and 2,478 had meaningful values. The average predicted market cap / fwd ffo (fy+2) of companies in the sector is 0.0x with a standard deviation of 0.0x.

Cumberland Pharmaceuticals Inc's Predicted Market Cap / Fwd FFO (FY+2) of 0.0x ranks in the 0.0% percentile for the sector. The following table provides additional summary stats:

Predicted Market Cap / Fwd FFO (FY+2) In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents2,479
Included Constituents2,478
Min0.0x
Max0.0x
Median0.0x
Mean0.0x
Standard Deviation0.0x

You can find companies with similar predicted market cap / fwd ffo (fy+2) using this stock screener.

All rights reserved. Terms Of Use